Healios
4593.TTSE GROWTHPharmaceutical
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥104m | ¥560m | ¥121m | ¥90m | ¥41m | ¥27m |
| Operating income | −¥3.3bn | −¥2.8bn | −¥3.4bn | −¥5.2bn | −¥5.4bn | — |
| Net income (owners) | −¥2.2bn | −¥4.2bn | −¥3.8bn | −¥5.2bn | −¥4.9bn | −¥5.5bn |
| Total assets | ¥17.1bn | ¥14.2bn | ¥15.2bn | ¥15.0bn | ¥24.0bn | ¥23.2bn |
| Net assets / equity | ¥4.9bn | ¥2.1bn | ¥3.9bn | ¥4.4bn | ¥8.6bn | ¥7.9bn |
| Operating cash flow | −¥3.2bn | −¥1.8bn | −¥2.8bn | −¥4.6bn | −¥5.1bn | −¥3.9bn |
| EPS (basic) | ¥-20.59 | ¥-47.86 | ¥-56.22 | ¥-90.67 | ¥-93.36 | ¥-107.2 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 82 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 197 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 82 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 196 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 100 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 82 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 199 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 106 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 106 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 82 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 191 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 106 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 106 figures · EDINET |
22 more reports are still being processed.